Inspire Medical Systems, Inc. (NYSE:INSP) Given Consensus Recommendation of "Hold" by Analysts

Key Points

• Analysts have a consensus “Hold” rating on Inspire Medical Systems, with 13 holds, three sells, three buys and one strong buy. The average 12-month price target is $68.
• Inspire reported quarterly EPS of $0.14, beating the consensus estimate of a $0.24 loss, while revenue of $200.6 million exceeded expectations but declined 7.6% year over year.
• The stock opened at $59.25, with a market capitalization of approximately $1.71 billion. Institutional investors own 94.91% of shares, while insider ownership stands at 2.20%; an insider recently sold 963 shares.

Inspire Medical Systems, Inc. (NYSE:INSP - Get Free Report) has earned an average recommendation of "Hold" from the twenty ratings firms that are presently covering the firm, MarketBeat reports. Three analysts have rated the stock with a sell rating, thirteen have issued a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. The average 12 month target price among analysts that have covered the stock in the last year is $68.00.

Several equities analysts have issued reports on the stock. Mizuho lifted their price target on shares of Inspire Medical Systems from $55.00 to $65.00 and gave the stock an "outperform" rating in a report on Tuesday, August 4th. Oppenheimer upgraded Inspire Medical Systems from a "market perform" rating to an "outperform" rating and set a $85.00 target price for the company in a research note on Tuesday, August 4th. KeyCorp reiterated a "sector weight" rating on shares of Inspire Medical Systems in a research note on Tuesday, August 4th. Royal Bank Of Canada reiterated a "sector perform" rating and issued a $60.00 price target on shares of Inspire Medical Systems in a report on Tuesday, August 4th. Finally, Piper Sandler increased their price target on Inspire Medical Systems from $55.00 to $60.00 and gave the stock a "neutral" rating in a research report on Tuesday, August 4th.

Inspire Medical Systems Trading Down 0.8%

INSP opened at $59.25 on Wednesday. The firm has a market cap of $1.71 billion, a price-to-earnings ratio of 12.83, a PEG ratio of 4.54 and a beta of 0.70. The stock has a fifty day moving average price of $48.39 and a 200-day moving average price of $53.75. Inspire Medical Systems has a 12 month low of $38.91 and a 12 month high of $147.03.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last released its quarterly earnings results on Monday, August 3rd. The company reported $0.14 earnings per share for the quarter, beating analysts' consensus estimates of ($0.24) by $0.38. The business had revenue of $200.58 million for the quarter, compared to analysts' expectations of $194.72 million. Inspire Medical Systems had a net margin of 15.03% and a return on equity of 8.64%. The company's revenue was down 7.6% compared to the same quarter last year. During the same period last year, the business earned $0.45 EPS. Inspire Medical Systems has set its FY 2026 guidance at 1.050-1.450 EPS. On average, equities research analysts forecast that Inspire Medical Systems will post 1.24 EPS for the current year.

Insiders Place Their Bets

In other Inspire Medical Systems news, insider Jason P. Kelly sold 963 shares of Inspire Medical Systems stock in a transaction on Friday, August 7th. The shares were sold at an average price of $59.55, for a total value of $57,346.65. Following the completion of the transaction, the insider owned 18,985 shares of the company's stock, valued at approximately $1,130,556.75. The trade was a 4.83% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 2.20% of the company's stock.

Hedge Funds Weigh In On Inspire Medical Systems

Large investors have recently bought and sold shares of the business. CWM LLC increased its position in shares of Inspire Medical Systems by 216.1% in the fourth quarter. CWM LLC now owns 354 shares of the company's stock valued at $33,000 after buying an additional 242 shares in the last quarter. EverSource Wealth Advisors LLC raised its stake in shares of Inspire Medical Systems by 1,115.4% during the 1st quarter. EverSource Wealth Advisors LLC now owns 632 shares of the company's stock worth $33,000 after buying an additional 580 shares during the period. Havemeyer Place LP acquired a new position in shares of Inspire Medical Systems during the 4th quarter worth approximately $39,000. V Square Quantitative Management LLC purchased a new position in shares of Inspire Medical Systems during the 4th quarter valued at approximately $40,000. Finally, Smartleaf Asset Management LLC lifted its position in shares of Inspire Medical Systems by 84.0% during the 4th quarter. Smartleaf Asset Management LLC now owns 449 shares of the company's stock valued at $42,000 after buying an additional 205 shares in the last quarter. Institutional investors and hedge funds own 94.91% of the company's stock.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company's flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source